EXACT Operating Margin from 2010 to 2026

EXAS Stock  USD 103.85  0.28  0.27%   
EXACT Sciences' Operating Profit Margin is increasing over recent years with slightly volatile volatility. It is projected to decline toward -0.032.
Review EXACT Sciences financial statements over time to add context on performance and capital structure. Track Interest Expense of 34.5 M, Other Operating Expenses of 3.5 B or Research Development of 549.1 M and ratios such as Price To Sales Ratio of 5.61, Dividend Yield of 0.0 or PTB Ratio of 4.65 to align performance context with EXACT Sciences Valuation and Volatility.
  
Build AI portfolio with EXACT Stock
Review EXACT Sciences Correlation against competitors for EXACT Sciences. This supports competitive context.
For information on how to trade EXACT Stock refer to our How to Trade EXACT Stock guide.
The evolution of Operating Margin for EXACT Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how EXACT Sciences compares to historical norms and industry peers.

Latest EXACT Sciences' Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of EXACT Sciences over the last few years. It is EXACT Sciences' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EXACT Sciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.09 %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

EXACT Operating Margin Regression Statistics

Arithmetic Mean-35.85
Coefficient Of Variation-345.77
Mean Deviation 58.62
Median-0.48
Standard Deviation 123.97
Sample Variance 15,368
Range514
R-Value 0.45
Mean Square Error 13,045
R-Squared 0.20
Significance 0.07
Slope 11.09
Total Sum of Squares 245,893

EXACT Operating Margin History

2026 -0.032
2025 -0.0305
2024 -0.38
2023 -0.086
2022 -0.28
2021 -0.48
2020 -0.51

Stock Overview, Methodology & Data Sources

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people. The stock overview for EXACT Sciences summarizes business drivers, financial profile, and market behavior. The company is positioned within Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 8.23, profit margin of -6.4%. EXACT Sciences has a market cap of 19.77 B, ROE of -8.66%.

Methodology

Unless otherwise specified, financial data for EXACT Sciences is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. EXACT (USA Stocks:EXAS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

EXACT Sciences has active sell-side coverage. Source-validated coverage currently shows 22 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 11 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Bernstein Research, Deutsche Bank, Morgan Stanley, BMO Capital Markets, Guggenheim Securities, Jefferies, Goldman Sachs, Evercore ISI, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 15th, 2026

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for EXACT Stock Analysis

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stocks Directory
Find actively traded stocks across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios